A Study of RO5217790 (HPV Targeted Immunotherapy) in Patients With High Grade Cervical Intraepithelial Neoplasia Associated With High Risk HPV Infection
This study is ongoing, but not recruiting participants.
Study NCT01022346
Information provided by Hoffmann-La Roche
First Received on November 20, 2009.
Last Updated on May 7, 2013
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
